Therapeutic compounds and methods
US7232829B2 · kind B2 · utility
0Cited by
29References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 6, 2001 |
| Grant date | Jun 19, 2007 |
| Priority date | — |
| Expiry date | May 15, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D489/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides kappa receptor agonists of formula (I) and delta receptor antagonists of formula (II), wherein R1–R6 X and n have any of the meanings given in the specification, as well as compositions comprising them, methods for their use, and synthetic procedures and intermediates useful for their preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.